Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

ALKTERNATE: A Pilot Study Alternating Lorlatinib with Crizotinib in ALK+ Non-Small Cell Lung Cancer with Prior ALK-inhibitor Resistance.

M. Itchins, S. Liang,C. Brown,T. Barnes,G. Marx,V. Chin,S. Kao,P.Y. Yip, A.J. Mersiades,A. Nagrial,V. Bray,G. Peters,S. Parakh, K. Garg,B.T. Li,M. McKay,K. O'Byrne,T. John,A.J. Gill,M. Molloy

JTO Clinical and Research Reports（2024）

Cited 0|Views2
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined